$402 Million is the total value of Eversept Partners, LP's 61 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AKRXQ | Exit | AKORN INC | $0 | – | -40,242 | -100.0% | -0.01% | – |
| RDUS | Exit | RADIUS HEALTH INCcall | $0 | – | -5,600 | -100.0% | -0.02% | – |
| TGTX | Exit | TG THERAPEUTICS INCcall | $0 | – | -41,500 | -100.0% | -0.08% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -11,795 | -100.0% | -0.08% | – |
| OPTN | Exit | OPTINOSE INC | $0 | – | -105,006 | -100.0% | -0.17% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCput | $0 | – | -275,600 | -100.0% | -0.18% | – |
| SBRA | Exit | SABRA HEALTH CARE REIT INC | $0 | – | -76,054 | -100.0% | -0.29% | – |
| HUM | Exit | HUMANA INC | $0 | – | -5,009 | -100.0% | -0.32% | – |
| CTRE | Exit | CARETRUST REIT INC | $0 | – | -107,464 | -100.0% | -0.40% | – |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -111,361 | -100.0% | -0.40% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -40,000 | -100.0% | -0.44% | – |
| LTC | Exit | LTC PPTYS INC | $0 | – | -59,327 | -100.0% | -0.47% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -10,000 | -100.0% | -0.53% | – |
| OHI | Exit | OMEGA HEALTHCARE INVS INC | $0 | – | -71,500 | -100.0% | -0.54% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -137,000 | -100.0% | -0.82% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -64,720 | -100.0% | -0.89% | – |
| NTRA | Exit | NATERA INC | $0 | – | -157,081 | -100.0% | -0.94% | – |
| RCM | Exit | R1 RCM INC | $0 | – | -416,726 | -100.0% | -0.96% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -17,750 | -100.0% | -1.04% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -37,204 | -100.0% | -1.06% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -73,400 | -100.0% | -1.14% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -1.71% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -114,358 | -100.0% | -1.72% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -73,009 | -100.0% | -2.82% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -305,726 | -100.0% | -3.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 24 | Q2 2024 | 12.5% |
| DANAHER CORPORATION | 24 | Q2 2024 | 8.1% |
| ARGENX SE | 22 | Q2 2024 | 2.9% |
| CENTENE CORP DEL | 21 | Q2 2024 | 1.5% |
| AFFIMED N V | 21 | Q4 2023 | 0.9% |
| BIOCRYST PHARMACEUTICALS INC | 20 | Q2 2024 | 3.8% |
| COMMUNITY HEALTH SYS INC NEW | 19 | Q2 2024 | 6.5% |
| ELEVANCE HEALTH INC | 19 | Q2 2024 | 2.5% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| COMMUNITY HEALTH SYSTEMS INC | February 14, 2024 | 7,231,126 | 5.3% |
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.